Solid Biosciences Inc.SLDBNASDAQ
LOADING
|||
Operating Income Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
-15.27%
↓ 137% below average
Average (36q)
-6.44%
Historical baseline
Range
High:29.36%
Low:-63.57%
Volatility
-1443.3%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -15.27% |
| Q2 2025 | -4.10% |
| Q1 2025 | -0.39% |
| Q4 2024 | -13.40% |
| Q3 2024 | -26.61% |
| Q2 2024 | -3.45% |
| Q1 2024 | -20.65% |
| Q4 2023 | 3.67% |
| Q3 2023 | 13.89% |
| Q2 2023 | 16.19% |
| Q1 2023 | 7.34% |
| Q4 2022 | -63.57% |
| Q3 2022 | 16.74% |
| Q2 2022 | -0.04% |
| Q1 2022 | -36.03% |
| Q4 2021 | -3.44% |
| Q3 2021 | 3.50% |
| Q2 2021 | -10.65% |
| Q1 2021 | 20.90% |
| Q4 2020 | -0.57% |
| Q3 2020 | -11.87% |
| Q2 2020 | 29.36% |
| Q1 2020 | 16.92% |
| Q4 2019 | -8.79% |
| Q3 2019 | -10.19% |
| Q2 2019 | 11.00% |
| Q1 2019 | -35.36% |
| Q4 2018 | -16.90% |
| Q3 2018 | -5.35% |
| Q2 2018 | -13.80% |
| Q1 2018 | -5.36% |
| Q4 2017 | -10.70% |
| Q3 2017 | -15.22% |
| Q2 2017 | 15.77% |
| Q1 2017 | -61.83% |
| Q4 2016 | 0.00% |
| Q1 2016 | 0.00% |